Skip to content

Home / News

News

Stay at the forefront of drug delivery innovation in the contract development and manufacturing organization (CDMO) space. Explore our latest news and announcements, where the demands of today meet the possibilities of tomorrow.

Company announcement

Kindeva joins forces with Rocket Science Health to pioneer new Intranasal Delivery Platform

18 JUNE 2025: Kindeva, a global CDMO and drug delivery expert, and Rocket Science Health (RSH), a Canadian technology healthcare company, have joined forces to find partners to develop a new intranasal delivery platform. RSH’s cutting-edge technology, combined with Kindeva’s CDMO capabilities, will supercharge the product journey as RSH prepares for commercial readiness.  The non-exclusive […]
Read more

News filter

Kindeva Drug Delivery and Orbia Fluorinated Solutions (Koura) announce collaboration for Low GWP Propellant Conversion

WOODBURY, Minn. and St. LOUIS, Mo. and BOSTON; Dec. 5, 2023 – Kindeva Drug Delivery (Kindeva), a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, and Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) Fluorinated Solutions business (Koura®), a global leader in the development, manufacture, and supply of fluoroproducts and […]

Read more

Meridian Medical Technologies, Kindeva Drug Delivery’s Global Health Security Division, awarded contract to supply DuoDote®

ST. LOUIS, Mo. and WOODBURY, Minn.; Nov. 14, 2023 (Business Wire) – Meridian Medical Technologies, LLC (Meridian), a division of Kindeva Drug Delivery (Kindeva), has been awarded a $9.9M contract to supply DuoDote® to the Administration for Strategic Preparedness and Response (ASPR) within the United States (U.S.) Department of Health and Human Services. Meridian is […]

Read more

Meridian Medical Technologies, LLC, and the European Commission’s DG HERA sign agreement for 13 countries from the EEA to purchase Tecovirimat SIGA

ST. LOUIS, Mo. and WOODBURY, Minn.; Oct. 23, 2023 (Business Wire) – Meridian Medical Technologies, LLC (Meridian), a global health security leader in providing medical countermeasures, today announced a framework contract under the Joint Procurement Agreement (JPA) was signed between Meridian and the European Commission’s Directorates-General (DG) HERA (Health Emergency Preparedness and Response Authority). As […]

Read more

Kindeva Drug Delivery appoints Brian Schubmehl as Chief Human Resources Officer

WOODBURY, Minn. and ST. LOUIS, Mo.; Sept. 15, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer. Schubmehl brings more than two decades of diverse and senior global leadership expertise that has […]

Read more

U.K. Government grant unlocks £33M investment with Kindeva Drug Delivery for greener inhaler future

WOODBURY, Minn. and ST. LOUIS, Mo.; Aug. 3, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that the company has received a grant from the U.K. Government’s Life Sciences Innovation Manufacturing Fund (LSIMF), unlocking a £33 million investment with Kindeva toward enhancing […]

Read more

Viatris announces launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first FDA-approved generic version of Symbicort® for people with asthma and chronic obstructive pulmonary disease, in partnership with Kindeva

Launch demonstrates companies’ commitment to bringing complex generic medicines to the market to help increase patient access PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca’s Symbicort® with an Abbreviated […]

Read more

Kindeva Drug Delivery, Chiesi Group, and H&T Presspart announce strategic partnership for Dose Counter Technology Production

Woodbury, Minn.; July 11, 2023 (Business Wire) – Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused […]

Read more

Meridian Medical Technologies, a Kindeva Drug Delivery company, investing $100+ Million in Bridgeton, Missouri, expansion

St. Louis, Mo. and St. Paul, Minn.; April 11, 2023 (Business Wire) – Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 […]

Read more

Kindeva Drug Delivery announces the appointment of David Stevens as Global CCO

ST. PAUL, Minn. and ST. LOUIS, Mo.; April 5, 2023 (Business Wire) – Kindeva Drug Delivery (Kindeva), a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced that David Stevens has joined the organization as global chief commercial officer (CCO). Stevens will spearhead the commercial, business development, and research and […]

Read more

Let’s transform tomorrow together

Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.